Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications

Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020

(2020) Neeraj Sood et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

(2020) Silvia Stringhini et al.   LANCET

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

(2020) Julian Braun et al.   NATURE

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

(2020) Nina Le Bert et al.   NATURE

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

(2020) Quan-Xin Long et al.   NATURE MEDICINE

The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

(2020) Naser Gharebaghi et al.   BMC INFECTIOUS DISEASES

Distinct clinical and immunological features of SARS–CoV-2–induced multisystem inflammatory syndrome in children

(2020) Pui Y. Lee et al.   JOURNAL OF CLINICAL INVESTIGATION

Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome

(2020) Harry Alexopoulos et al.   Neurology-Neuroimmunology & Neuroinflammation

Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice

(2019) Maria M. Dimitriadou et al.   Neurotherapeutics

Intravenous immunoglobulin: Exploiting the potential of natural antibodies

(2012) Srini V. Kaveri   AUTOIMMUNITY REVIEWS